“The Report Anti-Obesity Therapeutics – Pipeline Assessment and Market Forecasts to 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”
GlobalData, the industry analysis specialist, has released its new report, “Anti-Obesity – Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Anti-Obesity market. The report identifies the key trends shaping and driving the global Anti-Obesity market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Anti-Obesitysector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. GlobalData has estimated the global anti-obesity market to be valued at $1.1 billion in 2009. It is forecast to grow at a Compound Annual Growth Rate (CAGR) of 7% for the next seven years to reach $2 billion by 2017. The increasing patient population and high unmet need in terms of safety and efficacy will be the primary drivers of this growth. However, safety concerns with the current anti-obesity drugs and low prescription rates will remain major challenges to sustain this growth.
View Report @ http://www.marketresearchreports.biz/analysis/41720
The report provides information on the key drivers and challenges of the Anti-Obesity market. Its scope includes:
Annualized global Anti-Obesity market revenues data from 2001 to 2009, forecast for eight years to 2017.
Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as under appetite suppressants and calorie/fat absorption inhibitors.
Analysis of the current and future competition in the global Anti-Obesity market. Key market player covered are Orexigen Therapeutics, Novo Nordisk A/S and Takeda Pharmaceutical.
nsightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Anti-Obesity therapeutics market.
Get Sample Copy of this Report @
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global Anti-Obesitymarket.
Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Anti-Obesitymarket in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
What’s the next big thing in the global Anti-Obesitymarket landscape? – Identify, understand and capitalize.
Read our latest Press Release at
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA: Canada Toll Free: 866-997-4948